Study finds e-cigarettes can help smokers quit

E-cigarettes may actually help smokers quit, according to a recent study in the New England Journal of Medicine.

The study results strengthen the theory that e-cigarettes are an effective method to quit traditional smoking. While quitting traditional smoking is expected to reduce health risks, the risks of e-cigarettes are still somewhat unknown.

However, e-cigarettes were nearly twice as effective as other methods such as nicotine replacement products for quitting smoking, according to the study. The findings could also provide a much needed boost for e-cigarette companies like Juul, which has come under fire for allegedly promoting its products to teenagers. E-cigarette companies are currently facing threats of new regulations as usage among U.S. adults and teenagers continues to rise.

“There are questions about risks and benefits of use of e-cigarettes for different purposes, but an important clinical issue is whether e-cigarette use in a quit attempt facilitates success, particularly as compared with the use of nicotine-replacement therapy,” study author Peter Hajek, PhD, with the Wolfson Institute of Preventive Medicine at Queen Mary University of London, et al. wrote.

Researchers randomly assigned adults in the U.K.'s National Health Service stop-smoking services either nicotine-replacement products of their choice, such as gum or patches, for up to three months, or an e-cigarette starter pack. The treatment included weekly behavioral support for at least one month.

Out of the 866 participants in the randomized trial, the one-year abstinence rate was 18 percent in the e-cigarette group, compared to 9.9 percent in the nicotine-replacement group. The e-cigarette group was also more likely to still be using their assigned product after 52 weeks than the nicotine-replacement group, the study found.

However, throat or mouth irritation was reported more frequently among the e-cigarette group, 65.3 percent, compared to the nicotine-replacement group, 51.2 percent. Nicotine-replacement products caused more nausea, though the effects were mild, according to the results.

E-cigarettes may have been more successful in helping smokers quit for a few reasons, though the rate of continuing e-cigarette use was “fairly high,” Hajek and colleagues found. This could potentially pose other health problems long term.

“As in previous studies, e-cigarettes were more effective in alleviating tobacco withdrawal symptoms and received better ratings than nicotine-replacement therapy,” Hajek et al. wrote. “They may also have allowed better tailoring of nicotine dose to individual needs.”

Still, more research is needed on the subject, according to the researchers, who concluded that the results are likely to be valid for dependent smokers seeking help to quit. Another recent analysis found that millions of e-cigarette users have never smoked traditional tobacco cigarettes.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.